Search results - 4 results
COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022.
sampling.ResultsWe included 1,932,546 symptomatic individuals, of whom 734,115 tested positive. VE i against Delta waned from an initial estimate of 80% (95% confidence interval (CI): 80-81) to 55% (95% CI ...
Homologous versus heterologous prime-boost COVID-19 vaccination: impact on clinical severity of Omicron among hospitalized COVID-19 patients in Belgium
severe COVID-19 (RD =-0.04, 95% CI [-0.10–0.02]), ICU transfer (RD =-0.03, 95% CI [-0.07–0.02]), or inhospital mortality (RD =0.00, 95% CI [-0.05–0.04]) was found between homologous versus heterologous ...
Incidence and Risk Factors of COVID-19 Vaccine Breakthrough Infections: A Prospective Cohort Study in Belgium.
CI 11.2-11.3)/100 person years. Vaccination with Ad26. COV2.S (HR1.54, 95% CI 1.52-1.56) or ChAdOx1 (HR1.68, 95% CI 1.66-1.69) was associated with a higher risk of a breakthrough infection compared to ...
Directive Pratique pour la mise en place d'un système qualité dans les laboratoires d'anatomie pathologique agréés dans le cadre de l'Arrêté d'agrément
pathologique Système qualité Abstract: L’Arrêté Royal du 5 décembre 2011 concernant l’agrément des laboratoires d’anatomie pathologique (ci-dessous « l’Arrêté d’agrément ») liste les exigences de qualité ...